SYK and neoplasm: Most interestingly and compatible with the strong SYK inhibition observed in the LMP2A/MYC cells, TAK-659 was able to completely inhibit splenomegaly and tumor development in the Rag1KO mice that had received LMP2A/MYC cells (Fig. 4A).